News Feed
#politics
#society
#currentevents
#technology
#socialjustice
A space for sharing and discussing news related to global current events, technology, and society.
69465 Members
See All
Crypto
Economics
Culture
Ecology
Support
ALT-WOKE
Gaming
Artificial Life
We'll be adding more communities soon!
FAQ
|
Content Policy
|
Privacy Policy
© 2020 Relevant Protocols Inc.
News Feed
#politics
#society
#currentevents
#technology
#socialjustice
A space for sharing and discussing news related to global current events, technology, and society.
69465 Members
See All
Crypto
Economics
Culture
Ecology
Support
ALT-WOKE
Gaming
Artificial Life
We'll be adding more communities soon!
FAQ
|
Content Policy
|
Privacy Policy
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Community: News Feed
Get Started
Login
Relevant
Hot
New
Spam
Community: News Feed
Get Started
Login
0
43.1
US approves first new Alzheimer's drug in 20 years
bbc.com ↗︎
2 Comments
#alzheimer's
#research
#charity/aducanumab
#/us/dementia
#society
#currentevents
0
43.1
US approves first new Alzheimer's drug in 20 years
bbc.com ↗︎
2 Comments
#alzheimer's
#research
#charity/aducanumab
#/us/dementia
#society
#currentevents
kyawstar777
@kyawstar777 • 3 Years Ago
...
"There has been controversy around aducanumab, which targets the cause rather than the symptoms."
0
Reply
Share
kyawstar777
@kyawstar777 • 3 Years Ago
...
"There has been controversy around aducanumab, which targets the cause rather than the symptoms."
0
Reply
Share
Kyaw Zay Ya
@KyawZay75977933 • 3 Years Ago
...
>"There has been controversy around aducanumab, which targets the cause rather than the symptoms."
0
Reply
Share
Kyaw Zay Ya
@KyawZay75977933 • 3 Years Ago
...
>"There has been controversy around aducanumab, which targets the cause rather than the symptoms."
0
Reply
Share
Some low-ranking comments may have been hidden.
Show hidden comments
Some low-ranking comments may have been hidden.
Show hidden comments